Skip to Content

Increased incidence of new-onset type-2 diabetes after cancer

It’s well-known that metabolic dysfunction, as seen in diabetes, is associated with a higher risk of cancer. But does the same applies the other way around? A newly published Danish cohort suggests so. Get elaboration in this MEDtalk with Associate Professor Lykke Sylow on how cancer induces metabolic dysfunction and new-onset type-2 diabetes.

Lykke Sylow

Få tillgång till artikeln

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top